• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine

tetano

Editor, Senior Moderator
Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269-5. doi: 10.1016/j.vaccine.2016.12.044. [Epub ahead of print]
[h=1]The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.[/h] David SC[SUP]1[/SUP], Lau J[SUP]1[/SUP], Singleton EV[SUP]1[/SUP], Babb R[SUP]1[/SUP], Davies J[SUP]2[/SUP], Hirst TR[SUP]3[/SUP], McColl SR[SUP]1[/SUP], Paton JC[SUP]1[/SUP], Alsharifi M[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Gamma-irradiation, particularly an irradiation dose of 50kGy, has been utilised widely to sterilise highly pathogenic agents such as Ebola, Marburg Virus, and Avian Influenza H5N1. We have reported previously that intranasal vaccination with a gamma-irradiated Influenza A virus vaccine (γ-Flu) results in cross-protective immunity. Considering the possible inclusion of highly pathogenic Influenza strains in future clinical development of γ-Flu, an irradiation dose of 50kGy may be used to enhance vaccine safety beyond the internationally accepted Sterility Assurance Level (SAL). Thus, we investigated the effect of irradiation conditions, including high irradiation doses, on the immunogenicity of γ-Flu. Our data confirm that irradiation at low temperatures (using dry-ice) is associated with reduced damage to viral structure compared with irradiation at room temperature. In addition, a single intranasal vaccination with γ-Flu irradiated on dry-ice with either 25 or 50kGy induced seroconversion and provided complete protection against lethal Influenza A challenge. Considering that low temperature is expected to reduce the protein damage associated with exposure to high irradiation doses, we titrated the vaccine dose to verify the efficacy of 50kGy γ-Flu. Our data demonstrate that exposure to 50kGy on dry-ice is associated with limited effect on vaccine immunogenicity, apparent only when using very low vaccine doses. Overall, our data highlight the immunogenicity of influenza virus irradiated at 50kGy for induction of high titre antibody and cytotoxic T-cell responses. This suggests these conditions are suitable for development of γ-Flu vaccines based on highly pathogenic Influenza A viruses.
Copyright ? 2016. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Gamma-irradiation; Immunogenicity; Influenza A virus; Protective immunity

PMID: 28109709 DOI: 10.1016/j.vaccine.2016.12.044
[PubMed - as supplied by publisher]
 
Back
Top Bottom